| Recombinant human erythropoietin in the treatment of acute ischemic stroke H Ehrenreich, K Weissenborn, H Prange, D Schneider, C Weimar, ... Stroke 40 (12), e647-e656, 2009 | 716 | 2009 |
| Practice effects in healthy adults: A longitudinal study on frequent repetitive cognitive testing C Bartels, M Wegrzyn, A Wiedl, V Ackermann, H Ehrenreich BMC neuroscience 11, 1-12, 2010 | 447 | 2010 |
| Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies A Stuendl, M Kunadt, N Kruse, C Bartels, W Moebius, KM Danzer, ... Brain 139 (2), 481-494, 2016 | 434 | 2016 |
| Reduced oxidative damage in ALS by high‐dose enteral melatonin treatment JH Weishaupt, C Bartels, E Pölking, J Dietrich, G Rohde, B Poeggeler, ... Journal of pineal research 41 (4), 313-323, 2006 | 344 | 2006 |
| Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis H Ehrenreich, B Fischer, C Norra, F Schellenberger, N Stender, M Stiefel, ... Brain 130 (10), 2577-2588, 2007 | 277 | 2007 |
| Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system AL Sirén, T Faßhauer, C Bartels, H Ehrenreich Neurotherapeutics 6 (1), 108-127, 2009 | 265 | 2009 |
| Impact of SSRI therapy on risk of conversion from mild cognitive impairment to Alzheimer’s dementia in individuals with previous depression C Bartels, M Wagner, S Wolfsgruber, H Ehrenreich, A Schneider, ... American Journal of Psychiatry 175 (3), 232-241, 2018 | 165 | 2018 |
| Follow‐up of 180 alcoholic patients for up to 7 years after outpatient treatment: Impact of alcohol deterrents on outcome H Krampe, S Stawicki, T Wagner, C Bartels, C Aust, E Rüther, W Poser, ... Alcoholism: Clinical and Experimental Research 30 (1), 86-95, 2006 | 140 | 2006 |
| Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence C Bartels, HJ Kunert, S Stawicki, B Kröner-Herwig, H Ehrenreich, ... Alcohol and Alcoholism 42 (2), 92-102, 2007 | 111 | 2007 |
| Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study L Miebach, S Wolfsgruber, A Polcher, O Peters, F Menne, K Luther, ... Alzheimer's research & therapy 11 (1), 1-14, 2019 | 101 | 2019 |
| Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia T Wüstenberg, M Begemann, C Bartels, O Gefeller, S Stawicki, ... Molecular psychiatry 16 (1), 26-36, 2011 | 100 | 2011 |
| Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis BR Foerster, BA Dwamena, M Petrou, RC Carlos, BC Callaghan, ... Academic radiology 20 (9), 1099-1106, 2013 | 99 | 2013 |
| Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease N Franzmeier, E Düzel, F Jessen, K Buerger, J Levin, M Duering, ... Brain 141 (4), 1186-1200, 2018 | 92 | 2018 |
| Minor neuropsychological deficits in patients with subjective cognitive decline S Wolfsgruber, L Kleineidam, J Guski, A Polcher, I Frommann, S Roeske, ... Neurology 95 (9), e1134-e1143, 2020 | 74 | 2020 |
| EPO treatment preserves gray matter in discrete brain regions of chronic schizophrenic patients: Indication of areas with most progressive neurodegeneration inherent to the … T Wüstenberg, M Begemann, C Bartels, O Gefeller, S Stawicki, ... Molecular Psychiatry 16 (1), 1-1, 2011 | 69 | 2011 |
| The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease N Franzmeier, J Ren, A Damm, G Monté-Rubio, M Boada, A Ruiz, ... Molecular psychiatry 26 (2), 614-628, 2021 | 68 | 2021 |
| Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition H Ehrenreich, C Bartels, D Sargin, S Stawicki, H Krampe Journal of Renal Nutrition 18 (1), 146-153, 2008 | 66 | 2008 |
| Personality disorder and chronicity of addiction as independent outcomepredictors in alcoholism treatment H Krampe, T Wagner, S Stawicki, C Bartels, C Aust, B Kroener-Herwig, ... Psychiatric Services 57 (5), 708-712, 2006 | 61 | 2006 |
| Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system C Bartels, N Mertens, S Hofer, KD Merboldt, J Dietrich, J Frahm, ... Neuromuscular Disorders 18 (5), 398-407, 2008 | 57 | 2008 |
| Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis C Bartels, K Späte, H Krampe, H Ehrenreich Therapeutic advances in neurological disorders 1 (3), 193-206, 2008 | 52 | 2008 |
